Adagene Inc. in 1 story
The narratives ADAG currently appears in, with its side and exposure in each.
Bull side
1 story- China Becomes Pharma's Global R&D Engine
ADAG in “China Becomes Pharma's Global R&D Engine”
FadingExposure: not rated yetWestern drugmakers are licensing clinically validated Chinese molecules rather than relying solely on expensive in-house discovery.
Adagene gives public-market exposure to a China-founded antibody-engineering platform pursuing globally partnered and internally developed immuno-oncology programs.
Bear side
0 storiesNo bear-side stories for ADAG yet.